Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents

Clinical trial NCT04490018 · COMPLETED

Trial details

NCT number: NCT04490018
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Immunisation Healthy Volunteers

Start date: 2021-03-16
Primary completion: 2022-05-11
Enrollment: 463

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.